This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Other disorders involving the immune mechanism, not elsewhere classified
D3_IMMUNEMECHANISMOTHER
immune system disease: A disorder resulting from an abnormality in the immune system.
Endpoint definition
↥
FinnGen phenotype data
392423 individuals
Apply sex-specific rule None
392423
Check conditions None
392423
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
805
Check minimum number of events None
805
Remove individuals based on genotype QC
775
D3_IMMUNEMECHANISMOTHER
Control definitions
Control exclude
D3_IMMUNEMECHANISM
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D80-D89
Name in latin
Aliae perturbationes ad mechanismos immunales pertinentes non alibi classificatae
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Other disorders involving the immune mechanism, not elsewhere classified
based on the number of shared cases.
Broader endpoints:
- Certain disorders involving the immune mechanism
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any event in hilmo or specialist outpatient
- Any ICDMAIN event in hilmo or causes of death
- Any prescribed medicine buy
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 775 | 293 | 482 |
| Unadjusted prevalence (%) | 0.21 | 0.14 | 0.29 |
| Mean age at first event (years) | 48.34 | 44.37 | 50.76 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: D3_IMMUNEMECHANISMOTHER – Other disorders involving the immune mechanism, not elsewhere classified
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Other disorders involving the immune mechanism, not elsewhere classified
↥Endpoint not on priority list, no data to show.